Gastric cancer (GC) represents a global health concern. Despite advances in prevention,
diagnosis, and therapy, GC is still the third leading cause of cancer mortality worldwide, with …

The immensity of genes and molecules implicated in gastric carcinogenesis is
overwhelming and the relevant importance of some of these molecules is too often unclear …

This book is the third volume of the 4th Edition of the WHO series on histological and genetic
typing of human tumours. It is an authoritative, concise reference book providing an …

E‐cadherin expression disruption is commonly observed in metastatic epithelial cancers
and is a crucial step in gastric cancer (GC) initiation and progression. As aberrant …

Background Stomach cancer is the third deadliest among all cancers worldwide. Although
incidence of the intestinal-type gastric cancer has decreased, the incidence of diffuse-type is …

Gastric cancer (GC) is an important cause of morbidity and mortality worldwide. In addition to
environmental factors, genetic factors also play an important role in GC etiology, as …

Recent data supports a potentially significant role for immune checkpoint inhibitors in the
treatment of gastric cancer. However, there are few data on the clinical implications of …

Abstract Background Epstein-Barr Virus (EBV) is found in 10% of all gastric
adenocarcinomas but its role in tumor development and maintenance remains unclear. The …

AIM: To test the efficiency of a recently proposed histotype-based grading system in a
consecutive series of gastric cancers. METHODS: Two hundred advanced gastric cancers …

There is by no means a clear-cut pattern of mutations contributing to gastric cancers, and
gastric cancer research can be hampered by the diversity of factors that can induce gastric …